Cell Type Switch Helps Colon Cancer Evade Treatment, Study Suggests

Researchers in Germany have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed. The study, which will be published May 16 in the Journal of Experimental Medicine, suggests that combination therapies targeting both cell types at once may be more effective at treating colorectal cancer, the third highest cause of cancer-related death in the United States.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News